A Phase 4 interventional study of Adductor-Canal-Blockade and Adductor-Canal-blockade with saline in Total Knee Arthroplasty, sponsored by Copenhagen University Hospital, Rigshospitalet. Completed at 2 sites in Denmark. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2011-04-13.
Sponsored by Copenhagen University Hospital, Rigshospitalet · Phase 4, Interventional, and Treatment
The purpose of this study is to determine whether Adductor-Canal-Blockade is effective at reducing morphine consumption and pain, and at the same time improving mobilisation after total knee arthroplasty.
5,224 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.
This study's planned enrollment of 70 is close to the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Copenhagen University Hospital, Rigshospitalet is the lead sponsor of 34 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adductor-Canal-Blockade with ropivacaine
Procedure: Adductor-Canal-Blockade
Adductor-Canal-blockade with isotonic saline
Procedure: Adductor-Canal-blockade with saline
US-guided Adductor-Canal-Blockade with ropivacaine 7,5 mg/ml
Also known as: Naropine, Postoperative pain, US-guided nerve block
US-guided Adductor-Canal-blockade with saline
Also known as: placebo block
Total morphine consumption
Total morphine consumption at the interval 0-24 hours postoperative.
Time frame: 0-24 hours postoperative
Total morphine consumption
Total morphine consumption at the intervals 0-2, 0-4, 0-8 and 0-26 hours postoperative.
Time frame: 0-26 hours postoperative
Pain during rest
0-100 mm at a visual analogue scale (VAS), at the intervals 2, 4, 8, 24 and 26 hours postoperative, and the area under the curve for the intervals 2-24 and 24-26 hours postoperative.
Time frame: 0-26 hours postoperative
Pain during 45 degrees active flexion of the knee
0-100 mm at a visual analogue scale (VAS), at the intervals 2, 4, 8, 24 and 26 hours postoperative, and the area under the curve for the intervals 2-24 and 24-26 hours postoperative.
Time frame: 0-26 hours postoperative
A change in pain in the placebo group
0-100 mm at a visual analogue scale (VAS), at the intervals 24 and 26 hours postoperative.
Time frame: 24-26 hours postoperative
Postoperative nausea
Nausea scores(0-3)at 2,4,8,24,26 hours postoperative.
Time frame: 0-26 hours postoperative
Zofran consumption
Total zofran consumption at the intervals 0-24 and 24-26 hours postoperative.
Time frame: 0-26 hours postoperative
Sedation
Seadtion score (0-3) at 2,4,8,24,26 hours postoperative.
Time frame: 0-26 hours postoperative
Mobilisation
Number of seconds it takes to complete the "Timed Up and Go" test, at 20 and 26 hours postoperative.
Time frame: 20-26 hours postoperative
Postoperative vomiting
Number of vomiting episodes at the intervals 0-2,2-4,4-8,8-24,24-26 hours postoperative.
Time frame: 0-26 hours postoperative
This study is completed, as verified in Apr 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Copenhagen University Hospital, Rigshospitalet